Polyamines trong các khối u não ở người

Shimizu H, Kakimoto Y, Sano I: The determination and distribution of polyamines in mammalian nervous system. J Pharmac Exp Ther 143:199–204, 1964. Kremzner LT, Barrett RE, Terrano MJ: Polyamine metabolism in the central and peripheric nervous system. Ann NY Acad Sci 171:735–748, 1970. Kremzner LT: Polyamine metabolism in normal and neoplastic neural tissue. In: Russell DH (ed) Polyamines in normal and neoplastic growth. Raven Press, New York, 1973, pp 27–40. Seiler N: Polyamine metabolism in brain. In: Russel DH (ed) Polyamines in normal and neoplastic growth. Raven Press, New York, 1973, pp 137–156. Snyder SH, Shaskan EG, Harik S: Polyamine disposition in the central nervous system. In: Russell DH (ed) Polyamines in normal and neoplastic growth. Raven Press, New-York, 1973, pp. 199–213. Shaskan EG, Haraszti JH, Snyder SH: Polyamine: developmental alterations in regional disposition and metabolism in rat brain. J Neurochem 20:1443–1452, 1973. Shaw GG, Paterman AJ: The regional distribution of the polyamines spermidine and spermine in brain. J Neurochem 20:1225–1230, 1973. Shaskan EG, Snyder SH: Polyamine turnover in different regions of rat brain. J Neurochem 20:1453–1460, 1973. Harik SI, Snyder SH: Putrescine: regional distribution in the nervous system of the rat and the cat. Brain Res 66:328–331, 1974. Seiler N: Polyamine metabolism and function in brain. Neurochem Int 3:95–110, 1981. Shaw GG: The polyamines in the central nervous system. Biochem Pharmacol 28:1–6, 1979. Slotkin TA, Seidler FJ, Trepanier PA, Withmore WL, Lerea L, Barnes GA, Weigel SJ, Bartolome J: Ornithine decarboxylase and polyamines in tissues of the neonatal rat: effects of α-DFMO, a specific. irreversible inhibitor of ornithine decarboxylase. J Pharmacol Chem 222:741–745, 1982. Abbruzzese A, Della Pietra G, Porta R: Occurrence of 5′-deoxy-5′-methylthioadenosine phosphorylase in the mammalian CNS: distribution and kinetic studies on the rat brain enzyme. J Neurochem 40:487–492, 1983. Harik SI, Wehle SU, Sutton CH: Putrescine, a marker for malignant brain tumors. Neurology 28:351, 1978. Harik SI, Sutton CH: Putrescine as a marker of malignant brain tumors. Cancer Res 39:5010–5015, 1979. Scalabrino G, Modena D, Ferioli ME, Puerari M, Lucarelli G: Degrees of malignancy in human primary CNS tumors: ODC levels as better indicators than adenosylmethionine decarboxylase levels. JNCI 68:751–754, 1982. Marton LJ, Heby O, Wilson CB: Increased polyamine concentrations in the cerebrospinal fluid of patients with brain tumors. Int J Cancer 14:731–735, 1974. Marton LJ, Heby O, Levin VA, Lubich WP, Crafts DC, Wilson CB: The relationship of polyamines in cerebrospinal fluid to the presence of central nervous system tumors. Cancer Res 36:973–977, 1976. Fulton DS, Levin VA, Lubich WP, Wilson CB, Marton LJ: Cerebrospinal fluid polyamines in patients with glioblastoma multiforme and anaplastic astrocytoma. Cancer Res 40:3293–3296, 1980. Fulton DS, Marton LJ, Lubich WP, Wilson CB: Polyamine levels in CSF from patients with pituitary tumors or non neoplastic pituitary diseases. Arch Neurol 39:47–48, 1982. Marton LJ, Edwards MS, Levin VA, Lubich WP, Wilson CB: Predictive value of cerebrospinal fluid polyamines in medulloblastoma. Cancer Res 39: 993–997, 1979. Marton LJ: CSF polyamines, potential as brain tumor markers. Arch Neurol 38:73–74, 1981. Marton LJ, Edwards MS, Levin VA, Lubich WP, Wilson CB: CSF polyamines: A new and important means of monitoring patients with medulloblastoma. Cancer 47:757–760, 1981. Saeki Y, Vehara N, Shirakawa S: Sensitive fluorimetric method for the determination of putrescine, spermidine and spermine by high-performance liquid chromatography and its application to human blood. J Chromatogr 145:221–229, 1978. Pierangelli E, Levin VA, Seidenfeld J, Marton JL: Putrescine diffusion in cat brain and capillary permeability in rat brain: Relation to CSF putrescine levels in brain tumor patients. Eur J Cancer 17:143–147, 1981.